openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) over potential Wrongdoing

An investigation on behalf of current long term investors in Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) shares.

An investigation on behalf of current long term investors in Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) shares.

An investigation was announced for current long-term investors in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) concerning potential breaches of fiduciary duties by certain directors of Maravai LifeSciences Holdings, Inc.

Investors who are current long term investors in Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in (NASDAQ: MRVI stocks follows a lawsuit filed against Maravai LifeSciences Holdings, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: MRVI stocks, concerns whether certain Maravai LifeSciences Holdings, Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Southern District of California the plaintiff alleges that, the Defendants failed to disclose to investors that Maravai LifeSciences Holdings lacked adequate internal controls over financial reporting related to revenue recognition, that as a result, the Company inaccurately recognized revenue on certain transactions during fiscal 2024, that its goodwill was overstated, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) over potential Wrongdoing here

News-ID: 4008780 • Views:

More Releases from Shareholders Foundation, Inc.

Lawsuit filed for Investors who lost money with shares of Tronox Holdings plc (NYSE: TROX)
Lawsuit filed for Investors who lost money with shares of Tronox Holdings plc (N …
An investor, who purchased shares of Tronox Holdings plc (NYSE: TROX), filed a lawsuit over alleged violations of Federal Securities Laws by Tronox Holdings plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Tronox Holdings plc (NYSE: TROX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 3, 2025. NYSE: TROX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Investigation announced for Investors in Petco Health and Wellness Company, Inc. (NASDAQ: WOOF)
Investigation announced for Investors in Petco Health and Wellness Company, Inc. …
An investigation was announced for current long-term investors in shares of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) concerning potential breaches of fiduciary duties by certain directors of Petco Health and Wellness Company, Inc. Investors who are current long term investors in Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation
Investigation announced for Long-Term Investors in RxSight, Inc. (NASDAQ: RXST) over potential Wrongdoing
Investigation announced for Long-Term Investors in RxSight, Inc. (NASDAQ: RXST) …
An investigation was announced for current long-term investors in shares of RxSight, Inc. (NASDAQ: RXST) concerning potential breaches of fiduciary duties by certain directors of RxSight, Inc. Investors who are current long term investors in RxSight, Inc. (NASDAQ: RXST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: RXST
Tesla, Inc. (NASDAQ: TSLA) Investor Alert: Deadline in Lawsuit on October 3, 2025
Tesla, Inc. (NASDAQ: TSLA) Investor Alert: Deadline in Lawsuit on October 3, 202 …
A deadline is coming up on October 3, 2025 in the lawsuit filed for certain investors of Tesla, Inc. (NASDAQ: TSLA) over alleged securities laws violations by Tesla, Inc. Investors who purchased shares of Tesla, Inc. (NASDAQ: TSLA) have certain options and there are strict and short deadlines running. Deadline: October 3, 2025. Tesla, Inc. (NASDAQ: TSLA) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Maravai

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) Shareholder Notice: Deadline …
The Shareholders Foundation announced that a deadline is coming up on May 5, 2025 in the lawsuit filed for certain investors of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Investors who purchased shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) have certain options and there are strict and short deadlines running. Deadline: May 5, 2025. NASDAQ: MRVI stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
m-RNA Synthesis Service Market Future Business Opportunities 2025-2032 | Maravai …
Latest Report, titled "m-RNA Synthesis Service Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The m-RNA Synthesis Service market has been
m-RNA Synthesis Service Market Size, Share, Demand, Growth Statistics, and Trend …
Global m-RNA synthesis service market is estimated to be valued at US$ 6,438.6 Million in 2023 and is expected to exhibit a CAGR of 5.57% during the forecast period (2023-2030) The research report on the m-RNA Synthesis Service Market provides an in-depth analysis of the industry's current state and projected growth from 2024 to 2031. It presents key statistics, trends, and market dynamics that not only clarify the existing landscape but
Base Editing Market Top Companies Study - Danaher Corporation, Merck KgaA, Revvi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Base Editing Market - (by Product (Platform, Reagents & Kits, Plasmids, Base Editing Libraries), Service (gRNA Design, Cell Line Engineering), Type, Targeted base (Cytosine, Adenine), Application, End-User, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Base Editing Market is valued at US$ 273.1 Mn in
m-RNA Synthesis Service Market Overall Study Report 2024-2031 | Maravai LifeScie …
The Latest study titled m-RNA Synthesis Service Market 2024, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2024 to 2031. The comprehensive research delves into the evolving market dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. Additionally, the
m-RNA Synthesis Service Market: Growth, Challenges, and Opportunities Ahead by 2 …
New Research report, titled "m-RNA Synthesis Service Market" Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the worldwide market. The m-RNA Synthesis Service market has been growing significantly in recent years, driven by a number of key factors, such